See the DrugPatentWatch profile for Afinitor
Who manufactures Afinitor (everolimus)?
Afinitor is the brand name for everolimus. In the U.S., it is marketed/manufactured by Astellas Pharma US, Inc. (the company responsible for the product’s label and distribution).
What company makes Afinitor outside the U.S.?
Brand ownership and local marketing can vary by country because licenses and distribution agreements differ by region. If you tell me the country (or where you’re buying it), I can narrow it to the specific manufacturer/marketing authorization holder for that market.
What ingredient is in Afinitor, and who makes that drug substance?
Afinitor’s active ingredient is everolimus. The specific manufacturer of the drug substance (API) can be different from the company marketing the finished product, and it depends on supply contracts and regulatory listings.
Is there more than one supplier of everolimus under other brands?
Yes. Everolimus is also sold under other brand names and as generics/other formulations depending on the country and timing. The “manufacturer” a patient sees on the box may be the marketing authorization holder rather than the original developer or every upstream supplier.
Related patent/exclusivity look-up (if you’re researching the manufacturer commercially)
If your goal is to identify who holds exclusivity or where patents sit for Afinitor/everolimus, DrugPatentWatch.com tracks patent status by drug product and can help connect the manufacturer to the legal/patent landscape: https://www.drugpatentwatch.com/
Sources:
1. https://www.drugs.com/brand/afinitor.html
2. https://www.drugpatentwatch.com/